According to @demishassabis on Bloomberg Tech Europe, Isomorphic Labs is leveraging artificial intelligence to design new drug candidates that address challenging medical targets. The discussion with @TomMackenzieTV highlighted concrete progress in applying AI algorithms to accelerate drug discovery, reduce research timelines, and improve the accuracy of identifying promising compounds. This practical deployment of AI is opening significant business opportunities in the pharmaceutical sector, especially for companies aiming to tackle complex diseases that have traditionally been difficult to treat (source: Bloomberg Tech Europe, Sep 12, 2025).